stars 1 stars 2 stars 3

From the beginning of its development, PeriCoach has consulted with specialist clinicians to ensure that the final product meets the expectations of healthcare professionals and patients. We continue that approach through the appointment of Clinical Advisory Boards. In Australia, we have had a Clinical Advisory Board (CAB) approximately 12 months. Each member is a thought leader in their field, their opinions are respected by peers and colleagues in Australia and Internationally. The time commitment that these leaders have demonstrated is a significant validation of their belief in the clinical utility of PeriCoach. By engaging with the clinical community to understand their concerns and limitations with patient treatments, we can ensure patient identification is optimal and that a partnership between clinician and patient is created to promote best outcomes. We have deliberately identified clinicians from different disciplines within the area of pelvic health to ensure we meet the needs of all of our potential referral partners. The CAB has been instrumental in designing our clinical trial protocol, with 4 of its members providing the sites for patient recruitment. With most clinicians practicing Evidence Based Medicine, the data gathered from this trial will provide the independent proof to boost clinician and patient confidence.

PeriCoach Questions

The PeriCoach annual revenue was $5 million in 2026.

The NAICS codes for PeriCoach are [621, 6213, 62134, 62].

The SIC codes for PeriCoach are [804, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users